View Article

Abstract

Background: Vitamin A toxicity or hypervitaminosis A occurs when there is an excess of the vitamin A in the body that usually comes from supplements or the ingestion of foods with high proportions of the vitamin A content. Main Body: The damage to the liver from vitamin A toxicity is dose-dependent, which means that it is caused by either a high dose or a prolonged exposure to excess vitamin A. This can cause inflammation and structural damage in the liver. Diagnosis includes blood tests and symptoms associated with hypervitaminosis A. Treatment includes discontinuation of vitamin A intake, monitoring of the condition of the liver and further treatment in more severe cases. Most patients improve once the excess intake is discontinued. Conclusion: This Comprehensive review teaches us about managing liver health with dietary habits and shows the importance of dietary modification in the prevention and management of hypervitaminosis A. Vitamin A intake from both dietary and supplemental sources must be monitored so that serious health issues may not occur.

Keywords

Vitamin A, Provitamin A, Retinol, Retinal, Retinoic acid, Hypervitaminosis.

Introduction

Vitamin A toxicity, also known as hypervitaminosis A, can occur when the body absorbs excessive amounts of vitamin A from foods, dietary supplements, over-the-counter medications having vitamin A. There are both acute and long-term signs of toxic poisoning. Vitamin A overdose can result in acute toxicity. On the other hand, because of the significant build-up of vitamin A into the body, prolonged exposure results in chronic toxicity. Plants (pro-vitamin A) along with animal (preformed vitamin A) are the two sources of vitamin A. Beta-carotene is the most well known kind. Preformed vitamin A that is made up of a substance called retinol, retinoic acid, and esters of retinyl (1, 2). They are essential in the body's eyesight, reproduction, and immune system maintenance, among other physiological processes (3). The primary source of preformed vitamin A is dairy products, including milk, yogurt, and butter. Animal sources include chicken, beef, organ meats, fish, and fish-derived oils (2, 4). The body converts the provitamin A carotenoids found in vibrantly colored fruits and vegetables, such as papayas, sweet potatoes, and carrots, into the active vitamin A form (5).

After the intestinal breakdown of retinyl esters, the liver can store the resulting retinol. Hepatic stellate cells store most of the body's vitamin A in lipid droplets. Thus, the body can have enough vitamin A for long periods, even when food is not consumed. Upon release from the liver, retinol undergoes various metabolic processes, including oxidation to retinal (retinaldehyde) by retinol dehydrogenases (RDHs). Retinal can further oxidize to form retinoic acid, a potent signalling molecule that regulates gene expression. However, this conversion is irreversible, meaning that retinol cannot be converted back into retinal or retinoic acid once it has been converted. Retinoic acid binds to nuclear receptors, affecting gene transcription in cellular growth, differentiation, and immune response (5–7).
When someone unexpectedly consumes more than the suggested daily value of vitamin A, they are said to have acute hypervitaminosis A. Many upsetting symptoms may follow, showing up in days or weeks. Abdominal pain, nausea, vomiting, and excruciating headaches are possible side effects. They may experience additional changes to their skin and hair, such as peeling skin and hair loss, in addition to blurred eyesight and unusually lightheaded or irritated sensations. In more serious cases, excessive vitamin A can cause elevated blood pressure, which can lead to confusion and coma. On the other hand, chronic hypervitaminosis A develops more slowly and is typically brought on by prolonged high vitamin A administration. Numerous symptoms may appear, including exhaustion, dry skin, cheilosis (cracked lips), joint and muscular discomfort, and a generalised feeling of mental sluggishness. Liver damage may be indicated by abnormalities found in blood tests, such as increased liver enzymes and jaundice. Over time, chronic poisoning can cause serious liver issues including inflammation and scars, which can result in conditions like portal hypertension and cirrhosis. All forms of hypervitaminosis A serve as a crucial reminder to be cautious while taking vitamin A, particularly through certain foods and nutritional supplements. It's imperative to keep an eye on your vitamin A consumption to avoid serious health problems that could lead to both acute and chronic toxicity (4, 8).

Sources of Vitamin A:

Eggs, dairy products (such as cheese, butter, and dairy products), fish oils, liver, and orange and yellow produce (such as sweet potatoes, pumpkin, and carrots) are some of the animal and plant sources of vitamin A. Vitamin A is necessary for many different body functions. Papayas, mangoes, and apricots are among the fruits that increase the amount of vitamin A in the diet. Furthermore, some foods like cereals and margarine are enriched with vitamin A, and those who require them can obtain dietary supplements. Getting vitamin A from food products is generally advised to guarantee a balanced intake (9, 10).

Table: 01 Vitamin A content in dietary supplements and without the prescription product (1, 2).

Dietary supplies or consumable products

Vitamin A form

Recommended daily dose for adult men

Vitamin A content (µg RAE)

Liver from beef,0.085kg

Activated Vitamin A

731

6,582

One tablespoon of cod liver oil.

Activated Vitamin A

453

4,080

Centrum silver adults, 1tablet

Activated Vitamin A+ Provitamin A

83

750

1-cup Ricotta cheese part-skim.

Activated Vitamin A

31

263

1 cup Yogurt

Activated Vitamin A

4

32

Boiled egg (1 large)

Activated Vitamin A

8

75

Table: 02 The recommended dietary Requirement for vitamin A according to the National Institutes of Health [NIH] (1, 2).

Age

Milligrams (mg)

0 - 6 months

0.4 mg

7 - 12 months

0.5 mg

1 - 3 years

0.3 mg

4 - 8 years

0.4 mg

9 - 13 years

0.6 mg

14 - 18 years (pregnant females)

0.75 mg

14 - 18 years

0.9 mg for men, 700 µg for women

14 - 18 years (breastfeeding females)

1.2 mg

Above 19 years

0.9 mg for men, 0.7 mg for women

Above 19years (pregnant females)

0.77 mg

Above 19 years (breastfeeding females)

1.3 mg

Vitamin A Metabolism and Storage:

Vitamin A absorption occurs in the lumen of the small intestine. Micelles created with the help of bile acids are expelled from the gallbladder and picked up in the duodenum. Retinoid undergo further hydrolysis to yield retinol, and transport proteins help retinol absorb past the small intestine's brush barrier (2, 4). In the range of 70%-90% (preformed), vitamin A is absorbed through the stomach. Conversely, passive diffusion is how carotenoids are transferred. Retinol levels may take several months to return to normal following vitamin A poisoning due to the estimated 128-day half-life of vitamin A. In terms of storage, retinyl-esters are the most common. Enterocytes absorb the retinol and fatty acids produced when the digestive system breaks down the stored form of vitamin A. Retinol is made from beta-carotene and retinaldehyde, which are generated by the enzymatic conversion of carotenoids. Liver cells and cells lining of the intestines are responsible for processing. Retinol is converted into retinyl-esters by esterification with fatty acids. They enter the circulation after being integrated into chylomicrons in the liver. The circulatory system carries retinol to the hepatocytes and hepatic stellate cells. The most accurate measure of Vitamin A status is the hepatic retinyl-ester content. Only a small percentage of Vitamin A is deposited in the pancreas, intestines, kidneys, and lungs, which are the hepatic organs of the body; the majority (80%–90%) is stored in the liver (2, 4, 9, 11, and 12).  The most common place to store vitamin A is lipocytes, pericytes, fat-storing cells, or vitamin A-storing cells. Renin is converted to retinyl-esters in the liver's stellate cells and then stored in lipid droplets when taken in through the diet. Whenever there is a shortage of retinol in the body, these retinyl-esters are transferred back to hepatocytes for their utilization. Retinol-binding proteins are solely responsible for retinyl esters' bidirectional transport (2, 4, 9, and 13) (as illustrated in figure: 01).

Figure: 01 Transport & Storage of Vitamin A (13)

Vitamin A Cells & Pathway:

Vitamin A is a growth factor for cells, an immunocompetent vitamin, and an imperative vitamin for vision, among other biological functions. Thus, the levels of vitamin A in the organism are regulated by a large combination of enzymes and a few specific cell types within the liver. Among the many metabolic activities carried out by the hepatocytes, the primary activity of liver cells is the uptake and processing of vitamin A. Liver cells, or hepatocytes, take up retinol from the bloodstream, primarily obtained from the diet. Transport protein, the retinol-binding protein (RBP), in the blood, carries retinol to the tissues that need vitamin A. When the chylomicron remnants have been cleared from the circulation, the liver absorbs the remaining retinol through specific transport proteins, including the retinol transporter STRA6 and the fatty acid translocase CD36. The retinol is received into the liver cells, where retinol dehydrogenases, RDHs, degrade it into retinaldehyde. Another step is catalyzed by aldehyde dehydrogenases, mainly ALDH1A1 and ALDH1A2, which can further oxidize retinaldehyde into retinoic acid, the active form of vitamin A. This is a critical reaction, as retinoic acid controls cell differentiation and gene expression. Another vital role of hepatocytes is to excrete retinoic acid into bile. This action maintains proper vitamin A levels in the system and prevents accumulation. Another liver cell type is the hepatic stellate cells (HSCs), which store an unstated amount of vitamin A. LRAT is an enzyme that converts retinol into retinyl ester at the time of absorption in the liver. Such enzymes catalyze the interaction of retinol with fatty acyl-CoA, which is a necessary step in the mechanism by which HSCs maintain vitamin A in lipid droplets. Because of renin ester hydrolases, retinyl esters can be converted back into retinol either for release into circulation or to be converted to active forms under excess need for vitamin A. Kupffer cells are not principally storage cells, they can take up retinol and further contribute to to the conversion to retinoic acid by expressing enzymes that oxidize retinaldehyde (14–16) (as illustrated in figure: 02).

Figure: 02 Metabolism of Vitamin A in the Liver (6,12,17)

LRAT- lecithin retinol acyltransferase; DGAT- diglyceride acyltransferase; ADH1A- alcohol dehydrogenase 1A; AKR1B10- aldo-keto reductase family 1 member B10; BCMO1- beta-carotene monooxygenase; ALDH1A- aldehyde dehydrogenase 1 family member A; RBP4- retinol-binding protein 4.

Mechanisms of Liver Injury Due to Vitamin A Toxicity:

Damage to the liver due to vitamin A poisoning is dose-structured and can occur after short or sustained exposure to dangerously high dietary levels. When large doses are consumed, they can induce acute poisoning and liver damage. On the other hand, regular exposure to large dosages of vitamin A which can exceed 25,000 IU daily for extended periods of time causes chronic toxicity. The liver's natural structure and characteristics are compromised by this process. Additionally, oxidative strain, which is brought on by the accumulation of retinoic acid and retinaldehyde due to elevated vitamin A levels, can harm hepatocytes and produce inflammation in the liver. When reactive oxygen species are produced it damages the liver and other cells. Liver fibrosis and cirrhosis can occur as a result of chronic vitamin A poisoning. The dynamics of the liver's structural framework can be altered by excess collagen and other extracellular matrix proteins, leading to portal hypertension and compromised hepatic characteristics(13,18–23).

Signs Of Liver Toxicity Due To Hypervitaminosis A:

There are abnormally high alkaline phosphatase and aminotransferase levels, which can reach four times the suggested normalcy. Elevated serum antioxidant levels can be revealed. Liver biopsies reveal stellate cells, which are expanded and filled with lipids. The degree of sinusoidal sclerosis varies among these cells. The clinical evaluation is further guided by hypervitaminosis A symptoms, including skin changes, bone pain, and vision. Therefore, a multimodal approach integrating serum indicators, liver functioning tests, and clinical signs is necessary to accurately diagnose hypervitaminosis A and evaluate its effect on liver health(4,9) (as illustrated in Figure: 03)

Figure: 03 Signs of Liver Toxicity

Hypervitaminosis A Biomarkers:

The leading indicator used is serum retinol level, which typically has values between 20 and 60 mcg/dL. Levels above 200 mcg/dL indicate severe hypervitaminosis A, whereas levels over 100 mcg/dL may be toxic. Liver damage indicative of vitamin A overdose may be proven with the aid of necessary liver checks such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Other signs may additionally emerge when liver function is disturbed, which include improved alkaline phosphatase and blood lipid levels. In addition, an entire blood count (CBC) can screen hematological abnormalities associated with diet A intoxication(24,25).

Enzymes Involved in Vitamin A Liver Toxicity:

  1. Retinol Dehydrogenases (RDHs): A key player in the metabolism of vitamin A, retinal dehydrogenases (RDHs) transform retinol (dietary vitamin A alcohol) into retinaldehyde, which is subsequently broken down into retinoic acid, the active form that controls gene expression and cellular growth. A buildup of retinaldehyde results from the liver's inability to metabolize retinol in cases of hypervitaminosis A. This accumulation may lead to hepatotoxicity by causing oxidative stress and cellular damage in the liver (5–7,14,15,21).
  2. Aldehyde Dehydrogenases (ALDHs): In hypervitaminosis condition retinaldehyde level is increased due to the inability of ALDHs to convert retinaldehyde to retinoic acid using enzymes ALDH1A1 and ALDH1A2. This inability may affect the regular activities of cells and damage liver due to retinaldehyde accumulation (26, 27).
  3. Lecithin Retinol Acyltransferase (LRAT): LRAT enzyme is necessary for converting retinol to retinyl ester for storage of vitamin A in the liver but the inability of LRAT may  lead to the accumulation of retinol and its metabolites and damage liver cells by oxidative stress and hepatotoxicity(16,26).
  4. Cytochrome P450 Enzymes (CYPs): Essential enzymes CYP26A1 and CYP26B1 guard Retinoic acid levels. These enzymes protect against oxidative toxicity but their activity may be compromised in hypervitaminosis condition leading to severe liver damage (16, 25).

Diagnosis:

Doppler method is used to diagnose the liver, which comes under the ultrasound category. Several assessment parameters are used for the diagnosis of hypervitaminosis, which include the medical history of the patient, blood samples, and physical examination. Blood samples are usually taken from several frame components, which include the liver, kidneys, breast milk, crimson blood cells, and adipose tissue while testing for nutrition degrees. One more technique that is commonplace is immunoassays, including the retinoids-unique enzyme-related immunosorbent check (ELISA). This technique has a quicker detection time, reduces bioanalysis expenses, and is easy. By looking at the affected person's medical history, we will decide what caused the nutrition extra (10). A clinical exam can help hit upon any physical signs or signs of liver toxicity. Stopping excessive-dose vitamin A dietary supplements is the way to move for this circumstance. The majority of sufferers get better within a few weeks (4).

Table: 03 Technique for determination of carotenoids and retinoid in a biological system [4], [11].

Instruments

Bioanalysis

HPLC-UV-vis/DAD

Carotenoids, retinal, retinyl esters, retinoic acid, retinol.

HPLC-FLD

Retinol

LC-MS , LC-MS/MS

Retinol, Retinoic acid

ELISA kits

Retinol, Beta-carotene

HPLC/UHPLC-UV kits

Retinol, carotenoids

HPLC-ECD

Retinol, retinoic acid, carotenoids

SFC-MS/MS

Carotenoids, apocarotenoids, epoxy-carotenoids.

 

Management and Treatment:

 It may take some time for the liver to fully recover from the harm that excessive vitamin A dosages cause, but it is possible to do so by instructing patients to religiously avoid vitamin A pills and follow a low-vitamin A food regimen. Vitamin A toxicity can worsen symptoms of pre-existing liver disease. Therefore, people with these conditions should limit their vitamin A intake to what their bodies need. Liver function and liver enzyme levels need to be closely monitored in cases of greater severity where liver damage is more severe. Intense measures, such as possible liver transplantation, may be required if liver damage worsens; however, this is uncommon and usually saved for extreme situations. If hypervitaminosis A is identified early, it can be adequately treated. Once the consumption of vitamin A is stopped, along with supportive care, most patients recover completely (4, 8, 10, and 28).

CONCLUSION

When the body takes too much vitamin A from several sources, it can cause vitamin A toxicity, also called hypervitaminosis A. Vitamin A is necessary to properly function in several bodily systems, including the eyes, the reproductive system, and the immune system. The liver, a vital organ responsible for distributing blood and performing essential functions, can be affected by vitamin A toxicity. Treatment options for liver issues include medication, dietary and lifestyle changes, and liver transplantation in severe cases. Vitamin A absorption occurs in the small intestine and is stored primarily as retinyl-esters in the liver. The half-life of vitamin A is approximately 128 days, which means that retinol levels may take several months to return to normal following vitamin A poisoning. As a necessary nutrient, vitamin A is added to many foods in industrialized nations, particularly underdeveloped ones. To avoid both subclinical deficiency and toxicity, it is ideal for vitamin A status to be tracked as a component of an initiative in the public health domain. Although vitamin A deficiency is known to have harmful effects, more study is required to determine if toxicity occurs at the sub-clinical stage and how it affects general health and well-being.

Abbreviations:

RDHs: Retinol dehydrogenases

RBP: Retinol-binding protein

LRAT: Lecithin retinol acyltransferase

DGAT: Diglyceride acyltransferase

ADH1A: Alcohol dehydrogenase 1A

AKR1B10: Aldo-keto reductase family 1 member B10

BCMO1: Beta-carotene monooxygenase

ALDH1A: Aldehyde dehydrogenase 1 family member A

RBP4: Retinol-binding protein 4

AST: Aspartate aminotransferase

ALT: Alanine aminotransferase

DAD: diode array detection

FLD: fluorescence detection

LC-MS: Liquid chromatography-mass spectrometry

ELISA: Enzyme-linked immunosorbent assay

HPLC: High-performance liquid chromatography

SFC-MS: Supercritical fluid chromatography-mass spectrometry

UHPLC: Ultra-high-performance liquid chromatography

UV-vis: Ultraviolet-visible (UV-Vis) spectrophotometer

Declaration:

Ethics approval and consent to participate: Not Applicable

Consent for publication: Not Applicable 

Availability of data and material: No datasets were generated or analysed during the current study.

Competing interests: The authors declare no competing interests.

Funding: Not Applicable

Authors' contributions: Author’s contributions The Corresponding author completed the study protocol and was the primary organizer of data collection and the manuscript’s draft and revision process. The corresponding author wrote the article and ensured its accuracy.

Acknowledgements: The author thanks all the researchers who have made great efforts in their studies. Moreover, we are grateful to this journal’s editors, reviewers, and readers.

Clinical trial number: Not applicable.

REFERENCES

  1. Geraldine Moses AM. The safety of commonly used vitamins and minerals. Aust Prescr. 2021 Aug 1;44(4):119–23.
  2. Borgan SM, Khan LZ, Makin V. Hypercalcemia and vitamin A: A vitamin to keep in mind. Cleve Clin J Med. 2022;89(2):99–105.
  3. Zhang N, Cheng Y, Luo R, Chang D, Liu T, Wang Z, et al. Low-Carbohydrate-Diet Score and Mortality in Adults With and Without Chronic Kidney Disease: Results From the Third National Health and Nutrition Examination Survey. Journal of Renal Nutrition. 2022 May 1;32(3):301–11.
  4. Carazo A, Macáková K, Matoušová K, Kr?mová LK, Protti M, Mlad?nka P. Vitamin a update: Forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Vol. 13, Nutrients. MDPI AG; 2021.
  5. Kim CI, Leo MA, Lieber’ CS. Retinol Forms Retinoic Acid via Retinal’. Vol. 294, ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1992.
  6. Leo MA, Lasker JM, Raucy JL, Kim CI, Black M, Lteber2 CS. Metabolism of Retinol and Retinoic Acid by Human Liver Cytochrome P45OllC8’. Vol. 269, ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1989.
  7. Yamamoto Y, Zolfaghari R, Ross AC. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. Vol. 14, FASEB J. 2000.
  8. Roche HG. Vitamin A-Functions, dietary requirements and safety in humans [Internet]. Article in International Journal for Vitamin and Nutrition Research. 1997. Available from: https://www.researchgate.net/publication/14089589
  9. Delladetsima K, Manesis E, Tiniakos D, Sakellariou S. Complex liver injury induced by combined Aloe Vera and vitamin A oral supplements, as assessed by histology and the updated RUCAM. Explor Med. 2022;3(2):181–97.
  10. Fox R, Stace N, Wood K, French C. Liver toxicity from vitamin A. JGH Open. 2020 Apr 1;4(2):287–8.
  11. Saeed A, Bartuzi P, Heegsma J, Dekker D, Kloosterhuis N, de Bruin A, et al. Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes. CMGH. 2021 Jan 1;11(1):309-325.e3.
  12. D’Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: An update. Vol. 3, Nutrients. MDPI AG; 2011. p. 63–103.
  13. Vitamin A [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/
  14. Blaner WS. Retinol-Binding Protein: The Serum Transport Protein for Vitamin A*. 1989.
  15. Zanotti G, Berni R. Plasma Retinol-Binding Protein: Structure and Interactions with Retinol, Retinoids, and Transthyretin. 2004.
  16. Czuba LC, Isoherranen N. LX-2 Stellate Cells Are a Model System for Investigating the Regulation of Hepatic Vitamin A Metabolism and Respond to Tumor Necrosis Factor a and Interleukin 1b. Drug Metabolism and Disposition. 2024 May 1;52(5):442–54.
  17. Rietz P, Weber F. Metabolism of Vitamin A and the Determination of Vitamin A Status.
  18. Castaño G, Etchart C, Sookoian S. Vitamin A toxicity in a physical culturist patient: A case report and review of the literature. Vol. 5, Annals of Hepatology. Fundacion Clinica Medica Sur; 2006. p. 293–5.
  19. Pereira De Paula T, Arantes W, Peres F, Ramalho RA, Sérgio H, Coelho M. VITAMINA A E DOENÇA HEPÁTICA ALCOÓLICA | 601 Vitamin A metabolic aspects and alcoholic liver disease Aspectos metabólicos da vitamina A e doença hepática alcoólica. Vol. 19, Rev. Nutr., Campinas. 2006.
  20. Maqbool A, Graham-Maar RC, Schall JI, Zemel BS, Stallings VA. Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. Journal of Cystic Fibrosis. 2008 Mar;7(2):137–41.
  21. Melis M, Tang XH, Trasino SE, Gudas LJ. Retinoids in the Pathogenesis and Treatment of Liver Diseases. Vol. 14, Nutrients. MDPI; 2022.
  22. Dewett D, Lam-Kamath K, Poupault C, Khurana H, Rister J. Mechanisms of vitamin A metabolism and deficiency in the mammalian and fly visual system. Dev Biol. 2021 Aug 1;476:68–78.
  23. Czuba LC, Wu X, Huang W, Hollingshead N, Roberto JB, Kenerson HL, et al. Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis. Clin Transl Sci. 2021 May 1;14(3):976–89.
  24. Tanumihardjo SA. Vitamin A: Biomarkers of nutrition for development. Vol. 94, American Journal of Clinical Nutrition. 2011.
  25. Gholizadeh M, Basafa Roodi P, Abaj F, Shab-Bidar S, Saedisomeolia A, Asbaghi O, et al. Influence of Vitamin A supplementation on inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials. Sci Rep. 2022 Dec 1;12(1).
  26. Chen G, Weiskirchen S, Weiskirchen R. Vitamin A: too good to be bad? Vol. 14, Frontiers in Pharmacology. Frontiers Media S.A.; 2023.
  27. Napoli JL. Physiological insights into all-trans-retinoic acid biosynthesis. Vol. 1821, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 2012. p. 152–67.
  28. The acute and chronic toxic effects of vitamin A 1-4 Kristina L Penniston and Sherry A Tanumihardjo [Internet]. 2006. Available from: https://academic.oup.com/ajcn/article-abstract/83/2/191/4649798.

Reference

  1. Geraldine Moses AM. The safety of commonly used vitamins and minerals. Aust Prescr. 2021 Aug 1;44(4):119–23.
  2. Borgan SM, Khan LZ, Makin V. Hypercalcemia and vitamin A: A vitamin to keep in mind. Cleve Clin J Med. 2022;89(2):99–105.
  3. Zhang N, Cheng Y, Luo R, Chang D, Liu T, Wang Z, et al. Low-Carbohydrate-Diet Score and Mortality in Adults With and Without Chronic Kidney Disease: Results From the Third National Health and Nutrition Examination Survey. Journal of Renal Nutrition. 2022 May 1;32(3):301–11.
  4. Carazo A, Macáková K, Matoušová K, Kr?mová LK, Protti M, Mlad?nka P. Vitamin a update: Forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Vol. 13, Nutrients. MDPI AG; 2021.
  5. Kim CI, Leo MA, Lieber’ CS. Retinol Forms Retinoic Acid via Retinal’. Vol. 294, ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1992.
  6. Leo MA, Lasker JM, Raucy JL, Kim CI, Black M, Lteber2 CS. Metabolism of Retinol and Retinoic Acid by Human Liver Cytochrome P45OllC8’. Vol. 269, ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1989.
  7. Yamamoto Y, Zolfaghari R, Ross AC. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. Vol. 14, FASEB J. 2000.
  8. Roche HG. Vitamin A-Functions, dietary requirements and safety in humans [Internet]. Article in International Journal for Vitamin and Nutrition Research. 1997. Available from: https://www.researchgate.net/publication/14089589
  9. Delladetsima K, Manesis E, Tiniakos D, Sakellariou S. Complex liver injury induced by combined Aloe Vera and vitamin A oral supplements, as assessed by histology and the updated RUCAM. Explor Med. 2022;3(2):181–97.
  10. Fox R, Stace N, Wood K, French C. Liver toxicity from vitamin A. JGH Open. 2020 Apr 1;4(2):287–8.
  11. Saeed A, Bartuzi P, Heegsma J, Dekker D, Kloosterhuis N, de Bruin A, et al. Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes. CMGH. 2021 Jan 1;11(1):309-325.e3.
  12. D’Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: An update. Vol. 3, Nutrients. MDPI AG; 2011. p. 63–103.
  13. Vitamin A [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/
  14. Blaner WS. Retinol-Binding Protein: The Serum Transport Protein for Vitamin A*. 1989.
  15. Zanotti G, Berni R. Plasma Retinol-Binding Protein: Structure and Interactions with Retinol, Retinoids, and Transthyretin. 2004.
  16. Czuba LC, Isoherranen N. LX-2 Stellate Cells Are a Model System for Investigating the Regulation of Hepatic Vitamin A Metabolism and Respond to Tumor Necrosis Factor a and Interleukin 1b. Drug Metabolism and Disposition. 2024 May 1;52(5):442–54.
  17. Rietz P, Weber F. Metabolism of Vitamin A and the Determination of Vitamin A Status.
  18. Castaño G, Etchart C, Sookoian S. Vitamin A toxicity in a physical culturist patient: A case report and review of the literature. Vol. 5, Annals of Hepatology. Fundacion Clinica Medica Sur; 2006. p. 293–5.
  19. Pereira De Paula T, Arantes W, Peres F, Ramalho RA, Sérgio H, Coelho M. VITAMINA A E DOENÇA HEPÁTICA ALCOÓLICA | 601 Vitamin A metabolic aspects and alcoholic liver disease Aspectos metabólicos da vitamina A e doença hepática alcoólica. Vol. 19, Rev. Nutr., Campinas. 2006.
  20. Maqbool A, Graham-Maar RC, Schall JI, Zemel BS, Stallings VA. Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. Journal of Cystic Fibrosis. 2008 Mar;7(2):137–41.
  21. Melis M, Tang XH, Trasino SE, Gudas LJ. Retinoids in the Pathogenesis and Treatment of Liver Diseases. Vol. 14, Nutrients. MDPI; 2022.
  22. Dewett D, Lam-Kamath K, Poupault C, Khurana H, Rister J. Mechanisms of vitamin A metabolism and deficiency in the mammalian and fly visual system. Dev Biol. 2021 Aug 1;476:68–78.
  23. Czuba LC, Wu X, Huang W, Hollingshead N, Roberto JB, Kenerson HL, et al. Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis. Clin Transl Sci. 2021 May 1;14(3):976–89.
  24. Tanumihardjo SA. Vitamin A: Biomarkers of nutrition for development. Vol. 94, American Journal of Clinical Nutrition. 2011.
  25. Gholizadeh M, Basafa Roodi P, Abaj F, Shab-Bidar S, Saedisomeolia A, Asbaghi O, et al. Influence of Vitamin A supplementation on inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials. Sci Rep. 2022 Dec 1;12(1).
  26. Chen G, Weiskirchen S, Weiskirchen R. Vitamin A: too good to be bad? Vol. 14, Frontiers in Pharmacology. Frontiers Media S.A.; 2023.
  27. Napoli JL. Physiological insights into all-trans-retinoic acid biosynthesis. Vol. 1821, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 2012. p. 152–67.
  28. The acute and chronic toxic effects of vitamin A 1-4 Kristina L Penniston and Sherry A Tanumihardjo [Internet]. 2006. Available from: https://academic.oup.com/ajcn/article-abstract/83/2/191/4649798.

Photo
Heena Shaikh
Corresponding author

Department of Pharmacology, Oriental College of Pharmacy, Navi Mumbai

Photo
Fida Khanchey
Co-author

Department of Pharmacology, Oriental College of Pharmacy, Navi Mumbai

Photo
Nilesh Babre
Co-author

Department of Pharmacology, Oriental College of Pharmacy, Navi Mumbai

Photo
Faiz Ansari
Co-author

Department of Pharmacology, Oriental College of Pharmacy, Navi Mumbai

Photo
Juverya Kazi
Co-author

Department of Pharmacology, Oriental College of Pharmacy, Navi Mumbai

Heena Shaikh, Fida Khanchey, Nilesh Babre, Faiz Ansari, Juverya Kazi, Vitamin A Toxicity and Liver Dysfunction: Exploring Mechanisms, Symptoms, and Clinical Management, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 3105-3113. https://doi.org/10.5281/zenodo.15715982

More related articles
Formulation of Different Dosage Forms of Insulin ...
Shaikh Shirin Fatema Maulana, Waghmare Vyanktesh , Wangawar Palla...
Formulation And Evaluation of Anti-Fungal Cream...
Rutuja Desale , Paurnima Malik, Diksha Barde, Gayatri Bhere, Ashw...
Therapeutic Potential Of Azadirachtica Indica (Nee...
Diksha Sharma, Nikhil Kumar, Kapil Kumar Verma, ...
Formulation And Evaluation Of Buccoadhesive Drug Delivery System Containing A Br...
Akshay V. Patil, Dr. Gautam Mehetre, Vishal Murkute, Preeti More, ...
Organelle-Specific Drug Delivery Systems in the Treatment of Rare Mitochondrial ...
Raghav Dixit, Devinder Kumar Maheshwari, Shankar Gavaroji, Tanmay Ghosh, Narendra Mandoria, Ankur Pa...
Related Articles
Formulation And Evaluation Of Paracetamol Tablet To Assess ...
Somnath Wadghane , Rajesh Mokate, Jayshree Kokat, Puja Aher, ...
Cerimetric Estimation of Terazosin hydrochloride in Bulk Drugs and in Pharmaceu...
K. Prabhavathi, K. Nagaraja Setty, Sravanthi Chittela, ...
Novel Strategies in Drug Delivery System: A Review...
Rupesh Kumar , Ritu udan, V.M. Barethiya, Dr. R.H. kasliwal, Dr. K.P. Upadhye, ...
Formulation of Different Dosage Forms of Insulin ...
Shaikh Shirin Fatema Maulana, Waghmare Vyanktesh , Wangawar Pallavi , Shinde Devanand , Suryawanshi ...
More related articles
Formulation of Different Dosage Forms of Insulin ...
Shaikh Shirin Fatema Maulana, Waghmare Vyanktesh , Wangawar Pallavi , Shinde Devanand , Suryawanshi ...
Formulation And Evaluation of Anti-Fungal Cream...
Rutuja Desale , Paurnima Malik, Diksha Barde, Gayatri Bhere, Ashwini Kathore, Tejaswini Asawe, ...
Formulation of Different Dosage Forms of Insulin ...
Shaikh Shirin Fatema Maulana, Waghmare Vyanktesh , Wangawar Pallavi , Shinde Devanand , Suryawanshi ...
Formulation And Evaluation of Anti-Fungal Cream...
Rutuja Desale , Paurnima Malik, Diksha Barde, Gayatri Bhere, Ashwini Kathore, Tejaswini Asawe, ...